Dr Reddy’s registers PD-1 inhibitor for recurrent or metastatic nasopharyngeal carcinoma in South… EP News Bureau Aug 4, 2026 Dr Rashem Mothilal explains how the registration aims to expand access to immunotherapy for patients with recurrent or metastatic…
Dr. Reddy’s launches Toripalimab under the brand name Zytorvi in India EP News Bureau Nov 28, 2024 Toripalimab is an immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
Junshi Biosciences gets US FDA Breakthrough Therapy Designation for Toripalimab to treat… EP News Bureau Sep 11, 2020 It is the first anti-PD-1 antibody from China to receive BTD
